The government is taking steps to curb use of some long-acting asthma drugs taken by millions, issuing safety restrictions Thursday to lower an uncommon but potentially life-threatening risk that ...

Government health advisers Thursday called for restrictions on some long-acting asthma drugs, but spared Advair, a top-selling medication used by millions of patients. Government health advisers ...

— The government is taking steps to curb use of some long-acting asthma drugs used by millions. It issued safety restrictions Thursday to lower a life-threatening risk that asthma could worsen ...

GlaxoSmithKline is shifting its sales strategy for therapy Advair to stress increasing a treatment for chronic obstructive pulmonary disease (COPD), a new report states.Advair, a long-acting beta2 ...

It's no secret that respiratory drugs make up a crowded field, and forthcoming generics will make the competition tougher still. AstraZeneca's Symbicort is no stranger to the fallout, either, what ...

GSK and Theravance scored a win Wednesday when an FDA reviewing committee voted to recommend approval of their COPD drug Breo, which combines fluticasone furoate and vilanterol. The panel voted on a ...

Surveyed Physicians Who Identified Advair/Seretide/Adoair or Symbicort As the Most Efficacious Asthma Therapy Indicate High Levels of Satisfaction Across All Efficacy Attributes, According to Findings ...

LONDON, June 4 (Reuters) - AstraZeneca Plc is seeking U.S. approval to market its asthma drug Symbicort as a treatment for young children, increasing the competitive pressure on GlaxoSmithKline Plc's ...